HTLV-1 Infections

Overview

Journal J Clin Pathol

Specialty Pathology

Date 2000 Sep 26

PMID 11002759

Citations 30

Authors

C R Bangham

Affiliations

Soon will be listed here.

Abstract

Human T lymphotropic virus type 1 (HTLV-1) causes disabling and fatal diseases, yet there is no vaccine, no satisfactory treatment, and no means of assessing the risk of disease or prognosis in infected people. Recent research on the molecular virology and immunology of HTLV-1 shows the importance of the host's immune response in reducing the risk of these diseases, and is beginning to explain why some HTLV-1 infected people develop serious illnesses whereas most remain healthy life long carriers of the virus. These findings might be applicable to other persistent virus infections such as human immunodeficiency virus, hepatitis B, and hepatitis C.

Citing Articles

Advances in epigenetic treatment of adult T-cell leukemia/lymphoma: a comprehensive review.

Letafati A, Mehdigholian Chaijani R, Edalat F, Eslami N, Askari H, Askari F Clin Epigenetics. 2025; 17(1):39.

PMID: 40025589 PMC: 11871821. DOI: 10.1186/s13148-025-01841-z.

Dynamic Roles of RNA and RNA Epigenetics in HTLV-1 Biology.

King E, Panfil A Viruses. 2025; 17(1).

PMID: 39861913 PMC: 11769288. DOI: 10.3390/v17010124.

Characterization of HTLV-1 Infectious Molecular Clone Isolated from Patient with HAM/TSP and Immortalization of Human Primary T-Cell Lines.

Bellon M, Jain P, Nicot C Viruses. 2024; 16(11).

PMID: 39599870 PMC: 11599126. DOI: 10.3390/v16111755.

Establishment of a novel human T-cell leukemia virus type 1 infection model using cell-free virus.

Nagata K, Tezuka K, Kuramitsu M, Fuchi N, Hasegawa Y, Hamaguchi I J Virol. 2024; 98(2):e0186223.

PMID: 38294250 PMC: 10878273. DOI: 10.1128/jvi.01862-23.

Work ability and associated factors in people living with human T-cell leukemia virus type 1.

Costa D, Carvalho F, Vieira N, Falcao G, Sarmento V, Brites C Rev Soc Bras Med Trop. 2022; 55:e0111.

PMID: 35946625 PMC: 9344948. DOI: 10.1590/0037-8682-0111-2022.

References

Kira J, Koyanagi Y, Yamada T, Itoyama Y, Goto I, Yamamoto N . Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: a quantitative polymerase chain reaction study. Ann Neurol. 1991; 29(2):194-201. DOI: 10.1002/ana.410290214. View

Gout O, Gessain A, Iba-Zizen M, Kouzan S, Bolgert F, de The G . The effect of zidovudine on chronic myelopathy associated with HTLV-1. J Neurol. 1991; 238(2):108-9. DOI: 10.1007/BF00315691. View

Shimoyama M . Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol. 1991; 79(3):428-37. DOI: 10.1111/j.1365-2141.1991.tb08051.x. View

Hollsberg P, Wucherpfennig K, Ausubel L, Calvo V, Bierer B, Hafler D . Characterization of HTLV-I in vivo infected T cell clones. IL-2-independent growth of nontransformed T cells. J Immunol. 1992; 148(10):3256-63. View

Harrington Jr W, Sheremata W, Snodgrass S, Emerson S, Phillips S, Berger J . Tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM): treatment with an anabolic steroid danazol. AIDS Res Hum Retroviruses. 1991; 7(12):1031-4. DOI: 10.1089/aid.1991.7.1031. View

Mochizuki M, Watanabe T, Yamaguchi K, Takatsuki K, Yoshimura K, Shirao M . HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn J Cancer Res. 1992; 83(3):236-9. PMC: 5918816. DOI: 10.1111/j.1349-7006.1992.tb00092.x. View

Yoshida M, Seiki M, Yamaguchi K, Takatsuki K . Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci U S A. 1984; 81(8):2534-7. PMC: 345097. DOI: 10.1073/pnas.81.8.2534. View

Okochi K, Sato H, Hinuma Y . A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients. Vox Sang. 1984; 46(5):245-53. DOI: 10.1111/j.1423-0410.1984.tb00083.x. View

Kawano F, Yamaguchi K, Nishimura H, Tsuda H, Takatsuki K . Variation in the clinical courses of adult T-cell leukemia. Cancer. 1985; 55(4):851-6. DOI: 10.1002/1097-0142(19850215)55:4<851::aid-cncr2820550424>3.0.co;2-j. View

10.

Gessain A, Barin F, Vernant J, Gout O, Maurs L, Calender A . Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985; 2(8452):407-10. DOI: 10.1016/s0140-6736(85)92734-5. View

11.

Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A . HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986; 1(8488):1031-2. DOI: 10.1016/s0140-6736(86)91298-5. View

12.

Kamihira S, NAKASIMA S, Oyakawa Y, Moriuti Y, Ichimaru M, Okuda H . Transmission of human T cell lymphotropic virus type I by blood transfusion before and after mass screening of sera from seropositive donors. Vox Sang. 1987; 52(1-2):43-4. DOI: 10.1111/j.1423-0410.1987.tb02987.x. View

13.

Usuku K, Sonoda S, Osame M, Yashiki S, Takahashi K, Matsumoto M . HLA haplotype-linked high immune responsiveness against HTLV-I in HTLV-I-associated myelopathy: comparison with adult T-cell leukemia/lymphoma. Ann Neurol. 1988; 23 Suppl:S143-50. DOI: 10.1002/ana.410230733. View

14.

Sommerfelt M, Williams B, Clapham P, Solomon E, Goodfellow P, Weiss R . Human T cell leukemia viruses use a receptor determined by human chromosome 17. Science. 1988; 242(4885):1557-9. DOI: 10.1126/science.3201246. View

15.

Nishioka K, Maruyama I, Sato K, Kitajima I, Nakajima Y, Osame M . Chronic inflammatory arthropathy associated with HTLV-I. Lancet. 1989; 1(8635):441. DOI: 10.1016/s0140-6736(89)90038-x. View

16.

Kondo T, Kono H, Miyamoto N, Yoshida R, Toki H, Matsumoto I . Age- and sex-specific cumulative rate and risk of ATLL for HTLV-I carriers. Int J Cancer. 1989; 43(6):1061-4. DOI: 10.1002/ijc.2910430618. View

17.

Kawai H, Nishida Y, Takagi M, Nakamura K, Masuda K, Saito S . HTLV-I-associated myelopathy with adult T-cell leukemia. Neurology. 1989; 39(8):1129-31. DOI: 10.1212/wnl.39.8.1129. View

18.

Yoshida M, Osame M, Kawai H, Toita M, Kuwasaki N, Nishida Y . Increased replication of HTLV-I in HTLV-I-associated myelopathy. Ann Neurol. 1989; 26(3):331-5. DOI: 10.1002/ana.410260304. View

19.

Morgan O, Rodgers-Johnson P, Mora C, Char G . HTLV-1 and polymyositis in Jamaica. Lancet. 1989; 2(8673):1184-7. DOI: 10.1016/s0140-6736(89)91793-5. View

20.

MOORE G, Traugott U, SCHEINBERG L, Raine C . Tropical spastic paraparesis: a model of virus-induced, cytotoxic T-cell-mediated demyelination?. Ann Neurol. 1989; 26(4):523-30. DOI: 10.1002/ana.410260405. View